SCHEMBL19633346

SCHEMBL19633346

CCN1CCC2(CC1)CN(c1ccc(NC(=O)OC(C)(C)C)c([N+](=O)[O-])c1)C2

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 6/20 0.38
MAPT P10636 5/20 0.38
MAPK1 P28482 4/20 0.38
KDM4E B2RXH2 1/20 0.37
RECQL P46063 1/20 0.36
FGFR1 P11362 1/20 0.36
FGFR2 P21802 1/20 0.36
FGFR4 P22455 1/20 0.36
FGFR3 P22607 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PKM P14618 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30745794 1.00 TP53 (0.40) TP53MEN1KMT2AALDH1A1MAPT
SCHEMBL16653873 0.88 TP53 (0.47) TP53MEN1KMT2AALDH1A1MAPT
SCHEMBL19633356 0.88 KMT2A (0.38) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL30745784 0.88 ALDH1A1 (0.47) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL20836823 0.88 ALDH1A1 (0.47) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL20836800 0.86 TP53 (0.47) TP53MEN1KMT2AALDH1A1MAPT
SCHEMBL19633241 0.83 ALDH1A1 (0.47) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL979759 0.81 KMT2A (0.53) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL19633244 0.81 KMT2A (0.44) TP53KMT2AALDH1A1MAPTMAPK1
SCHEMBL16071753 0.81 MAPK1 (0.51) TP53MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018130-A1 Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2024-01-18 US disclosed
US-11827625-B2 Pyrimidine derivative, method for preparing same and use thereof in medicine ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. 2023-11-28 US disclosed
WO-2017198221-A1 PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME AND USE THEREOF IN MEDICINE 浙江海正药业股份有限公司 2017-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827625-B2 Pyrimidine derivative, method for preparing same and use thereof in medicine FGFR4, FGFR1, FGFR2 TP53 1736/4885MEN1 2284/4885KMT2A 1729/4885
US-20240018130-A1 Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine FGFR4, FGFR1, FGFR2 TP53 1736/4885MEN1 2284/4885KMT2A 1729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.